european
societi
vascular
surgeri
esv
carotid
guidelin
well
subsequ
literatur
review
recommend
clopidogrel
monotherapi
combin
aspirin
dipyridamol
recent
symptomat
patient
undergo
carotid
endarterectomi
cea
patient
schedul
cea
antiplatelet
therapi
recommend
throughout
periop
period
longterm
advis
earli
treatment
aspirin
clopidogrel
aspirin
dipyridamol
may
consid
order
prevent
earli
recurr
event
patient
transient
ischaem
attack
tia
minor
ischaem
stroke
ipsilater
stenosi
await
expedit
cea
evid
iib
level
c
howev
esv
write
group
unabl
recommend
routin
aspirin
clopidogrel
therapi
patient
treat
cea
medic
therapi
compel
evid
time
strategi
confer
addit
benefit
antiplatelet
monotherapi
also
concern
aspirin
clopidogrel
would
increas
bleed
complic
patient
undergo
urgent
cea
new
data
recent
publish
randomis
control
trial
rct
conjunct
unforeseen
consequ
evolv
pandem
mandat
urgent
review
antiplatelet
strategi
recent
symptomat
patient
prasad
et
al
base
metaanalysi
three
rct
chanc
point
faster
patient
randomis
within
h
experienc
minor
ischaem
stroke
nihss
highrisk
tia
defin
abcd
score
aspirin
monotherapi
shortterm
aspirin
clopidogrel
combin
therapi
recommend
bmj
rapid
guidelin
document
compel
evid
support
shortterm
treatment
dual
antiplatelet
therapi
dapt
patient
subgroup
fundament
chang
recommend
toward
routin
prescript
shortterm
dapt
patient
tia
minor
stroke
assum
even
greater
relev
due
consequ
pandem
current
wreak
havoc
health
system
around
world
health
provid
radic
reconfigur
way
hospit
work
includ
convert
oper
theatr
intens
care
facil
inevit
knock
effect
abil
perform
elect
even
urgent
surgic
intervent
includ
carotid
endarterectomi
cea
vascular
endovascular
research
network
vern
establish
seri
onlin
survey
vascular
surgic
practic
around
world
gaug
effect
pandem
workflow
march
april
centr
report
impact
pandem
carotid
surgeri
practic
half
centr
still
abl
follow
nationalintern
guidelin
chang
practic
howev
centr
indic
treat
recent
symptomat
patient
tia
minor
stroke
best
medic
therapi
multidisciplinari
team
review
said
would
offer
cea
patient
crescendo
symptom
enter
strategi
thano
saratzi
person
commun
therefor
essenti
patient
realli
receiv
best
medic
therapi
bmj
panel
confid
compar
aspirin
monotherapi
aspirin
clopidogrel
dapt
start
within
h
symptom
onset
reduc
risk
nonfat
data
consist
anoth
metaanalysi
chanc
point
data
arr
nonfat
recurr
ischaemichaemorrhag
stroke
ari
major
haemorrhag
bmj
panel
conclud
dapt
continu
day
benefit
term
recurr
stroke
prevent
occur
first
day
symptom
onset
base
awar
dapt
reduc
recurr
stroke
per
popul
possibl
increas
moder
sever
bleed
per
laymemb
bmj
panel
conclud
nonfat
stroke
time
wors
seriou
gastrointestin
gi
bleed
patient
would
opt
cours
dapt
chang
clopidogrel
monotherapi
thereaft
number
guidelin
adopt
chanc
point
data
recommend
shortterm
aspirin
clopidogrel
dapt
day
patient
minor
noncardioembol
ischaem
stroke
receiv
intraven
tissu
plasminogen
activ
day
day
patient
highrisk
tia
minor
ischaem
stroke
assumpt
patient
continu
clopidogrel
aspirin
monotherapi
thereaft
howev
guidelin
provid
specif
advic
regard
antiplatelet
strategi
recent
symptomat
patient
stenosi
consider
urgent
ceaca
may
exclud
inclus
chancepoint
unresolv
concern
potenti
heighten
risk
periop
bleed
complic
associ
dapt
import
whilst
highqual
evid
support
prescript
dapt
patient
tiaischaem
stroke
without
stenosi
evid
rct
balanc
benefit
vs
risk
favour
prescrib
dapt
recent
symptomat
patient
stenosi
prior
cea
esv
guidelin
recommend
cea
perform
soon
possibl
symptom
onset
order
prevent
earli
recurr
stroke
inevit
delay
seen
rapid
access
tia
clinic
undergo
cea
time
patient
vulner
recurr
thromboembol
stroke
overview
naturalhistori
studi
involv
tia
patient
ipsilater
stenosi
risk
earli
recurr
stroke
risk
howev
nonrandomis
evid
earli
recurr
stroke
might
prevent
earli
institut
dapt
would
consist
latest
rct
find
recent
audit
h
delay
patient
seen
tia
clinic
undergo
cea
time
experienc
recurr
stroketia
decis
made
start
dapt
tia
clinic
parenchym
haemorrhag
exclud
ctmr
recurr
clinic
event
prior
cea
fell
fivefold
associ
fourfold
reduct
rate
spontan
embolis
transcrani
doppler
ultrasound
addit
perform
expedit
cea
patient
dapt
associ
significantli
increas
risk
periop
bleed
complic
overal
practic
empir
advic
might
offer
updat
esv
carotid
guidelin
await
due
especi
current
pandem
order
balanc
potenti
benefici
effect
earli
dapt
reduc
earli
recurr
stroke
prior
ceaca
concern
bleed
complic
given
patient
treat
ca
routin
prescrib
aspirin
clopidogrel
prior
intervent
dapt
start
soon
possibl
prior
ca
advis
esv
guidelin
debat
therefor
move
patient
consid
optim
medic
therapi
includ
centr
unabl
perform
cea
due
pandem
patient
still
abl
undergo
expedit
cea
three
scenario
surgeonvascular
neurologiststrok
physician
may
face
patient
present
highrisk
tiaminor
ischaem
stroke
earli
institut
dapt
rather
antiplatelet
monotherapi
may
prefer
treatment
strategi
stenosi
mechan
tiastrok
comprehens
neurovascular
workup
recent
tia
stroke
plu
stenosi
ceaca
definit
consid
patient
fit
patient
prefer
due
pandem
recent
tiastrok
plu
stenosi
urgent
cea
plan
one
also
need
decid
whether
remain
appropri
prescrib
dapt
h
elaps
symptom
onset
first
two
scenario
rel
straightforward
fig
extrapol
evid
noncarotid
stenosi
patient
popul
highrisk
tia
minor
stroke
support
mg
load
dose
clopidogrel
patient
plu
mg
aspirin
alreadi
aspirin
patient
could
treat
clopidogrel
mg
daili
aspirin
mg
daili
day
follow
clopidogrel
mg
daili
aspirin
mg
daili
day
thereaft
patient
revert
longterm
monotherapi
clopidogrel
mg
daili
patient
stenosi
altern
would
prescrib
aspirin
mg
daili
day
reduc
longterm
aspirin
dose
mg
daili
combin
dipyridamol
modifi
releas
mr
mg
daili
day
increas
mg
bd
thereaft
furthermor
patient
symptomat
stenosi
much
higher
risk
recurr
vascular
event
decis
made
undergo
ceaca
clopidogrel
contraind
altern
strategi
would
prescrib
aspirin
mg
daili
day
reduc
longterm
aspirin
dose
mg
daili
combin
fulldos
dipyridamol
mr
mg
bd
day
toler
import
note
physician
report
recent
histor
difficulti
access
prescrib
dipyridamol
person
commun
medic
readili
avail
mani
countri
main
debat
therefor
relat
group
patient
present
recent
symptomat
stenosi
await
expedit
cea
fig
heighten
risk
recurr
tiastrok
preoper
surgeon
happi
perform
expedit
cea
aspirin
clopidogrel
dapt
parenchym
haemorrhag
first
exclud
ctmri
patient
commenc
aspirin
mg
stat
alreadi
aspirin
follow
aspirin
mg
daili
combin
clopidogrel
mg
daili
day
without
mg
load
dose
expedit
cea
care
control
postop
blood
pressur
perform
uncontrol
postcea
hypertens
increas
risk
hyperperfus
syndrom
intracrani
haemorrhag
neck
haematoma
format
aspirin
stop
day
cea
clopidogrel
mg
daili
continu
indefinit
unless
contraind
whilst
chanc
point
faster
includ
patient
within
h
symptom
onset
one
certain
surgeon
perform
expedit
cea
aspirin
clopidogrel
seem
reason
start
dapt
patient
present
h
tiaminor
stroke
onset
especi
within
first
day
risk
earli
recurr
stroke
highest
also
import
prescrib
gastric
protect
proton
pump
inhibitor
interact
clopidogrel
eg
pantoprazol
patient
prescrib
dapt
reduc
gi
bleed
complic
per
esv
guidelin
surgeon
happi
perform
cea
aspirin
clopidogrel
altern
would
prescrib
aspirin
mg
daili
day
reduc
longterm
aspirin
dose
mg
daili
combin
dipyridamol
mr
mg
twice
daili
day
advic
regard
potenti
side
effect
regimen
effect
reduc
microemboli
aspirin
clopidogrel
patient
recent
symptomat
extracrani
carotid
stenosi
microemboli
transcrani
doppler
ultrasound
howev
one
must
accept
limit
data
risk
pericea
bleed
complic
aspirin
dipyridamol
therapi
surgeon
may
still
prefer
continu
aspirin
monotherapi
periop
mg
daili
howev
must
accept
latest
evid
suggest
aspirin
monotherapi
less
effect
combin
therapi
risk
recurr
stroke
anti
thrombot
therapi
usual
aspirin
mg
daili
even
patient
underw
cea
nascet
question
rais
regard
benefit
test
antiplatelet
resist
commonli
refer
high
ontreat
platelet
reactiv
htpr
ex
vivo
platelet
functionreact
test
antiplatelethtpr
potenti
risk
factor
vascular
event
antiplatelet
therapi
studi
date
adequ
power
definit
comment
whether
ex
vivo
htpr
statu
predict
risk
clinic
outcom
event
asymptomat
symptomat
carotid
stenosi
patient
periop
nonperiop
phase
preval
antiplatelethtpr
also
posit
influenc
shear
stress
level
platelet
expos
ex
vivo
platelet
function
test
platform
question
accordingli
studi
requir
determin
whether
one
could
optimis
secondari
prevent
use
personalis
antiplatelet
regimen
tailor
suit
individu
patient
carotid
stenosi
base
antiplatelethtpr
statu
first
day
onset
symptom
remain
highest
risk
period
experienc
recurr
stroke
index
event
histor
vascular
surgeon
may
realli
consid
prevent
recurr
stroke
prior
final
decis
regard
need
cea
primari
respons
need
chang
compel
rct
evid
earli
institut
aspirin
clopidogrel
significantli
reduc
earli
recurr
stroke
highrisk
tia
minor
ischaem
stroke
aspirin
clopidogrel
dapt
need
continu
day
also
increas
anecdot
evid
grow
bodi
surgeon
will
perform
expedit
cea
aspirin
clopidogrel
dapt
reduc
rate
earli
recurr
stroke
prior
cea
aspirin
clopidogrel
dapt
may
also
reduc
earli
postop
thrombot
stroke
well
whilst
pandem
led
sometim
radic
seemingli
unthink
chang
practic
regard
abil
perform
urgent
cea
mani
centr
even
import
patient
highrisk
tia
minor
ischaem
stroke
due
recent
symptomat
carotid
stenosi
unabl
undergo
ceaca
start
shortterm
aspirinclopidogrel
dapt
longterm
aspirindipyridamol
combin
therapi
soon
possibl
pandem
subsid
surgeon
still
face
question
optimis
antiplatelet
therapi
recent
symptomat
patient
prior
cea
direct
indirect
evid
suggest
strategi
outlin
confer
overal
benefit
patient
without
significantli
increas
haemorrhag
risk
associ
carotid
intervent
none
none
pleas
cite
articl
naylor
